CSF2 and Parkinson disease: It is important to underscore that the 6-OHDA paradigm presently used provoked a very modest loss of striatal terminals and future studies are required to ascertain whether GM-CSF and EPO might also have reparative properties in PD models with more significantly sized lesions.